Related Experiment Video
Updated: Aug 6, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Rational Prescribing and Deprescribing of Antihypertensive Medications in Older People, Part 2
Patrick Russell1, Campbell Thompson2, Arduino A Mangoni3
11 Department of Internal Medicine, Royal Adelaide Hospital, Adelaide, South Australia.
Insights
Blood pressure control benefits robust older adults, reducing illness and death. However, overly aggressive treatment may be harmful, especially for frail individuals with complex health conditions.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Clinical Pharmacology
Background:
- Strong evidence supports blood pressure (BP) control in healthy older adults for reducing morbidity and mortality.
- Historical debate exists regarding intensive hypertension treatment in older populations, informed by randomized controlled trials (RCTs) and observational studies.
- Early studies indicated a J-shaped curve for mortality, suggesting a risk associated with overly low BP levels.
Purpose of the Study:
- To evaluate the nuances of BP targets in older adults, considering varying health statuses.
- To address the exclusion of complex and frail older individuals from pivotal BP control trials.
- To determine if current BP targets are appropriate for all older adult populations.
Main Methods:
- Review of epidemiological studies and randomized controlled trials (RCTs) on hypertension management in older adults.
- Analysis of cohort studies focusing on complex and frail older populations.
- Examination of the concept of "too low" BP and its implications for different geriatric subgroups.
Main Results:
- While BP control is beneficial for robust older adults, a "too low" BP threshold may exist and vary.
- Complex and frail older individuals, often excluded from RCTs, may have different optimal BP targets.
- The decision to initiate or discontinue BP-lowering medication requires careful consideration of individual patient factors.
Conclusions:
- Individualized BP management is crucial for older adults, accounting for frailty and comorbidities.
- Current generalized BP targets may not be suitable for all elderly patients, particularly the frail.
- Further research is needed to establish tailored BP guidelines for diverse older adult populations.
Abstract:
The evidence is strong in favor of blood pressure (BP) control in robust older people as a way to reduce morbidity and mortality in the same way that treatment improves the lives of middle-aged people. Expert editorials have been written over the last five decades persuasively arguing for or against more intensive treatment of older people with hypertension, supported by the specificity of (then) contemporaneous randomized controlled trials (RCTs) or the generalizability of observational studies. But there are limitations.First, there has always been such a thing as too low. Early epidemiological studies showed an upward inflection in mortality curves that resemble a slanted letter J. Second, certain complex older people encountered routinely in a clinic, pharmacy, or nursing facility were often excluded from the RCTs showing benefit from intensive BP control. Cohort studies of these complex people showed a different truth, that the point of "too low" might move up and that BP targets for adults might be too low for select older people. Not all older people are the same. Some are burdened by frailty superimposed on cardiovascular disease and a limited life-expectancy. It is one thing not to start BP-lowering medications for this patient; it is an entirely different matter to stop.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension IV: Drug Therapy and Lifestyle Modifications
Factors Affecting Drug Response: Overview
Hypertension V: Nursing Management
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...

